|
HK1133649A1
(en)
|
|
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
HK1245088A1
(en)
|
|
Modulation of activity of proneurotrophins
|
|
DK2117523T3
(en)
|
|
Inhibitors of AKT activity
|
|
DK1898903T3
(en)
|
|
Inhibitors of Akt activity
|
|
IL187344A0
(en)
|
|
Compounds modulating c-kit and c-fms activity and uses therefor
|
|
DK3181682T3
(en)
|
|
REDUCED COLONIZATION OF MICROBES ON THE MUCKINS
|
|
DK3208269T3
(en)
|
|
INHIBITORS OF C-FMS CHINASE
|
|
CL2014003228A1
(en)
|
|
Synthesis and intermediates of biologically active heterocyclic compounds.
|
|
DE602007008155D1
(en)
|
|
Expansion of the communication capabilities of industrial controller systems
|
|
DK2498771T3
(en)
|
|
USE OF BETHANECHOL FOR THE TREATMENT OF XEROSTOMY
|
|
DK2504005T3
(en)
|
|
USE OF 1,3-DIPHENYLPROP-2-ONE-1-DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES
|
|
DE112007000789A5
(en)
|
|
Use of Bora tetraazepentalene
|
|
FI20065757A0
(en)
|
|
Use of beta-lactamase
|
|
DK2209900T3
(en)
|
|
USE OF BACTERIA FOR THE MANUFACTURE OF BIOENERGY
|
|
SE0801744L
(en)
|
|
Monitoring of epileptiform activity
|
|
BRPI0818348A2
(en)
|
|
N- (PIRAZOL-3-IL) -BENZAMIDE DERIVATIVES AS GLUCKINASE ACTIVATORS
|
|
DK2167095T3
(en)
|
|
PHENOTHIAZIN COMPOUNDS FOR TREATMENT OF LOW COGNITIVE DISABILITY
|
|
BRPI0915394A2
(en)
|
|
purification of modified cytokines
|
|
DK2164572T3
(en)
|
|
Carbamoyl-cyclohexanes for the treatment of acute mania
|
|
DK2117565T3
(en)
|
|
APPLICATION OF CHITOSANES FOR THE TREATMENT OF NON-FLAMMATORY DISEASES
|
|
BRPI0816290A2
(en)
|
|
ISOLATION OF PELLET-MAKING MICRO-ORGANISMS
|
|
BRPI0912481A2
(en)
|
|
peroxide activators of metallocarbene complexes
|
|
TH0701005851B
(en)
|
|
Compounds controlling the activity of C-FMS and/or C-KIT and applications therefor
|
|
DE602006005899D1
(en)
|
|
Risk assessment of planned trajectories
|
|
ES1062668Y
(en)
|
|
PERFECTED STRUCTURE OF INDUSTRIAL VESSELS
|